Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

De Clercq Erik

doi:10.1016/0304-3835(79)90017-x

Back

Shared by

De Clercq Erik

KU Leuven

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

Article 1979 en

Related publications

Article2024

Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses

Xiangyi Jiang, Waleed A. Zalloum, Zhen Gao, Jiaojiao Dai, Xiangkai Ji, Minghui Xie, Guanyu Dong, De Clercq Erik, Boshi Huang, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Authors

De Clercq Erik
KU Leuven

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Article2023

Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability

De Clercq Erik, Shuai Wang, Fen‐Er Chen, Ya-Li Sang, Christophe Pannecouque

Article1998

Mutational Analysis of Tyr-318 within the Non-nucleoside Reverse Transcriptase Inhibitor Binding Pocket of Human Immunodeficiency Virus Type I Reverse Transcriptase

Heidi Pelemans, Robert Esnouf, Heidi Jonckheere, De Clercq Erik, Jan Balzarini

Article2003

Validation of a Model for the Complex of HIV-1 Reverse Transcriptase with Nonnucleoside Inhibitor TMC125

Marina Udier–Blagović, Julian Tirado‐Rives, William L. Jorgensen

Journal of the American Chemical Society

Article2015

Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance

William T. Gray, Kathleen M. Frey, Sarah B. Laskey, Andrea C. Mislak, Krasimir A. Spasov, Won-Gil Lee, Mariela Bollini, Robert F. Siliciano, William L. Jorgensen, Karen S. Anderson

ACS Medicinal Chemistry Letters